Biotheranostics hologic login
WebJan 5, 2024 · – Transaction Accelerates Hologic’s Entry into Oncology Growth Market, Provides New Lab Capabilities – – Hologic’s Commercial Resources, Expertise in … WebThis Notice of privacy practices describes how Biotheranostics may use and disclose individuals’ health information, whether collected on our website or off-line, and is posted in compliance with HIPAA. Questions. ... Hologic, Biotheranostics, Breast Cancer Index, CancerTYPE ID and associated logos are trademarks and/or registered trademarks ...
Biotheranostics hologic login
Did you know?
WebBCI uses her original tissue specimen, no additional biopsy needed. Formalin-fixed, paraffin-embedded (FFPE) tissue block preferred, or. 3-4 unstained, 10µm-thick sections on glass slides (an area of tumor that contains ≥40% neoplastic cells) and one H&E-stained slide. WebJan 6, 2024 · January 6, 2024 By Sean Whooley. Hologic (NSDQ: HOLX) announced that it agreed to acquire molecular diagnostic test maker Biotheranostics for approximately $230 million. Privately held, commercial ...
WebJan 5, 2024 · Biotheranostics generated approximately $33 million of revenue in calendar 2024. The acquisition is expected to be slightly dilutive to Hologic’s non-GAAP earnings per share in fiscal 2024, break-even in 2024, and accretive thereafter. The acquisition is expected to close in February of 2024, subject to antitrust clearance and other customary ... WebJan 5, 2024 · MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, announced today that it has agreed to acquire …
WebFeb 22, 2024 · MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, has completed its previously announced … WebJan 6, 2024 · On Monday, it announced acquisition of Somatex Medical for $64 million, a buy also in the women's health space. Hologic's $230 million valuation is roughly seven …
WebBreast Cancer Index™ (BCI) is the only test recognized by NCCN Clinical Practice Guidelines in Oncology (NCCN ® Guidelines) and the American Society of Clinical …
WebJan 5, 2024 · MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, announced today that it has agreed to acquire … dgh hof aktuellWebFeb 23, 2024 · February 23, 2024 By Sean Whooley. Hologic (NSDQ: HOLX) announced that it completed its previously announced acquisition of Biotheranostics for $230 million. Marlborough, Mass.-based Hologic last ... cibc smart balanced portfolioWebJan 5, 2024 · On January 5, 2024, Hologic acquired life science company Biotheranostics for 230M USD Acquisition Highlights. This is Hologic’s 2nd transaction in the Life Science sector. This is Hologic’s 7th largest (disclosed) transaction. This is Hologic’s 15th transaction in the United States. This is Hologic’s 4th transaction in California. dgh herbornWebJan 5, 2024 · MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, announced today that it has agreed to acquire Biotheranostics, Inc., a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, for approximately $230 million, … dghheWebJan 5, 2024 · SPX. +1.87%. Medical technology company Hologic Inc. HOLX, +0.71% said late Tuesday it has agreed to buy privately held Biotheranostics Inc. for $230 million. Biotheranostics, which generated ... dgh healthWebShip with specimen to Biotheranostics' laboratory OR fax this form to 800-266-9607 and Biotheranostics will request the specimen from Pathology. NeoTYPE Discovery Profile ... Biotheranostics, Inc., A Hologic Company 9640 Towne Centre Drive Suite 200 San Diego, CA 92121 www.CancerTYPEID.com Client Services (877) 886-6739 Fax (800) … cibc simply financialWebApr 13, 2024 · Maryland Lab Permit-revised 04.13.2024 no expiration date.pdf. Pennsylvania Clinical Lab Permit-expires-08-15-2024.pdf. cibc smart account interest